|
GB9619757D0
(en)
*
|
1996-09-21 |
1996-11-06 |
Knoll Ag |
Chemical process
|
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
|
DK1093370T3
(da)
*
|
1998-06-30 |
2006-05-22 |
Takeda Pharmaceutical |
Farmaceutisk præparat til behandling af diabetes
|
|
US6476078B2
(en)
*
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
US6331571B1
(en)
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
|
US6339106B1
(en)
|
1999-08-11 |
2002-01-15 |
Sepracor, Inc. |
Methods and compositions for the treatment and prevention of sexual dysfunction
|
|
US6974838B2
(en)
|
1998-08-24 |
2005-12-13 |
Sepracor Inc. |
Methods of treating or preventing pain using sibutramine metabolites
|
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
|
DZ2937A1
(fr)
*
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
|
WO2000028989A1
(en)
*
|
1998-11-12 |
2000-05-25 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
|
US6696495B2
(en)
|
1998-12-02 |
2004-02-24 |
Snowden Pharmaceuticals, Llc |
Treatment of disorders secondary to organic impairments
|
|
US6323242B1
(en)
|
1998-12-02 |
2001-11-27 |
Peter Sterling Mueller |
Treatment of disorders secondary to organic impairments
|
|
US6552087B1
(en)
|
1999-03-19 |
2003-04-22 |
Abbott Gmbh & Co. Kg |
Therapeutic agent comprising (+)-sibutramine
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
AR018699A1
(es)
|
1999-06-01 |
2001-11-28 |
Procter & Gamble |
Metodo para el tratamiento de la perdida del cabello el cual comprende administrar una composicion que comprende un compuesto el cual no afecta al corazon
|
|
GB9914744D0
(en)
*
|
1999-06-24 |
1999-08-25 |
Knoll Ag |
Therapeutic agents
|
|
US6399826B1
(en)
|
1999-08-11 |
2002-06-04 |
Sepracor Inc. |
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
|
|
US6610887B2
(en)
|
2001-04-13 |
2003-08-26 |
Sepracor Inc. |
Methods of preparing didesmethylsibutramine and other sibutramine derivatives
|
|
US8911781B2
(en)
|
2002-06-17 |
2014-12-16 |
Inventia Healthcare Private Limited |
Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
|
|
HRP20050307A2
(en)
*
|
2002-10-05 |
2006-12-31 |
Hanmi Pharm. Co. Ltd. |
Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
|
|
US20050131074A1
(en)
*
|
2003-08-04 |
2005-06-16 |
Beckman Kristen M. |
Methods for treating metabolic syndrome
|
|
UY28457A1
(es)
*
|
2003-08-07 |
2005-03-31 |
Sb Pharmco Inc |
Nueva composición
|
|
GB0318824D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Glaxo Group Ltd |
Novel composition
|
|
PL1677792T3
(pl)
*
|
2003-10-31 |
2016-05-31 |
Takeda Pharmaceuticals Co |
Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym
|
|
KR100627687B1
(ko)
*
|
2005-04-20 |
2006-09-25 |
주식회사 씨티씨바이오 |
시부트라민 유리염기 함유 조성물 및 이의 제조방법
|
|
CA2636324C
(en)
*
|
2006-01-06 |
2012-03-20 |
Sepracor Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
|
WO2008034142A2
(en)
|
2006-09-15 |
2008-03-20 |
Reviva Pharmaceuticals, Inc. |
Synthesis, methods of using, and compositions of cycloalkylmethylamines
|
|
KR100812538B1
(ko)
*
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
|
BRPI0716002A2
(pt)
*
|
2006-11-22 |
2013-07-30 |
Sk Chemicals Co Ltd |
complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade
|
|
EP2118123B1
(en)
|
2007-01-31 |
2015-10-14 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
EP3159352B1
(en)
|
2007-03-28 |
2023-08-02 |
President and Fellows of Harvard College |
Stitched polypeptides
|
|
US20110024043A1
(en)
|
2009-07-02 |
2011-02-03 |
Dexcom, Inc. |
Continuous analyte sensors and methods of making same
|
|
WO2012003501A2
(en)
|
2010-07-02 |
2012-01-05 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
|
|
KR102104762B1
(ko)
|
2010-08-13 |
2020-04-24 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
US9238625B2
(en)
|
2011-12-30 |
2016-01-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
|
|
NZ627528A
(en)
|
2012-02-15 |
2016-05-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles
|
|
CA2864120A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
KR20170058424A
(ko)
|
2014-09-24 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티드모방 거대고리 및 이의 용도
|
|
SG11201707750YA
(en)
|
2015-03-20 |
2017-10-30 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|